Google Gemini Co-Lead Noam Shazeer Leaves for OpenAI Amid AI Talent Race 
G7 Explores AI Access Deal With U.S. Amid Anthropic Restrictions 
Kingboard Holdings Shares Surge After HK$11.77 Billion Block Trade to Expand PCB and AI Supply Chain Business 
Qantas Nears Launch of World’s Longest Non-Stop Flights to London and New York 
Meta Seeks Legal Shield From Child-Harm Lawsuits Amid KOSA Talks 
GM and Lockheed Martin Partner to Strengthen U.S. Defense Manufacturing Capacity 
Obayashi to Acquire Multiplex in $526M Expansion Deal 
SoftBank Shares Drop as OpenAI Losses and Rising Costs Spark Investor Concerns 
Samsung Gains Interest from BYD, Google, AMD as AI Chip Demand Strains TSMC Capacity 
HSBC Australia Faces A$35M Penalty Over Scam Protection Failures 
Trump Says Anthropic No Longer Seen as National Security Threat 
J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand 
SK Hynix Shares Hit Record High After Shipping Next-Generation HBM4E AI Memory Samples 
Jio IPO Filing Nears as Reliance Targets $4 Billion Market Debut 
Carro Expands Into Australia With Acquisition of Used-Car Platform CarPlace 
US Raises Concerns Over Possible ASML EUV Machine Transfer to China 
Dublin, Dec. 07, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/8bqskf/transdermal_drug) has announced the addition of Jain PharmaBiotech's new report "Transdermal Drug Delivery - Technologies, Markets, and Companies" to their offering.
The market for transdermal drug delivery is analyzed according to technologies and therapeutic areas from 2014 to 2024
This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes. Various transdermal drug delivery technologies are described including the use of suitable formulations, carriers and penetration enhancers.
The most commonly used transdermal system is the skin patch using various types of technologies. Nanoparticles as well as the use of physical agents to facilitate transcutaneous drug delivery is described. Microneedle and needleless technologies are also described.
Transdermal technologies may be applied for several categories of pharmaceuticals used for the treatment of disorders of the skin or for systemic effect to treat diseases of other organs. Several transdermal products and applications include hormone replacement therapy, contraception, management of pain, angina pectoris, smoking cessation and neurological disorders such as Parkinson's disease.
Benefits of this report:
- Up-to-date one-stop information on transdermal drug delivery
- Description of 109 companies involved and 110 collaborations in this area
- Market analysis 2014-2024
- Market values in major regions
- Strategies for developing markets for transdermal drug delivery
- A selected bibliography of 220 publications
- Text is supplemented by 22 tables and 13 figures
Key Topics Covered:
Executive Summary
1. Basics of Transdermal Drug Delivery
2. Transdermal Drug Delivery Technologies
3. Transdermal Therapeutics
4. Markets for Transdermal Drug Delivery
5. Companies involved in transdermal drug delivery
6. References
For more information visit http://www.researchandmarkets.com/research/8bqskf/transdermal_drug
Source: Jain PharmaBiotech
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Transdermal and Transmucosal Drug Delivery
